galantamine and Akinetic-Rigid Variant of Huntington Disease

galantamine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, K; Im, WS; Kim, M; Lee, ST; Park, JE1
Aw, CC; Browne, ER; Chan, EC; Chang, KL; Goh, CW; Mal, M; New, LS1
Andreou, C; Bozikas, VP; Karavatos, A; Petrikis, P; Piachas, A1

Other Studies

3 other study(ies) available for galantamine and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease.
    Neuroscience letters, 2008, Dec-19, Volume: 448, Issue:1

    Topics: Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Galantamine; Huntington Disease; In Situ Nick-End Labeling; Male; Nerve Degeneration; Neurologic Examination; Nitro Compounds; Nootropic Agents; Propionates; Rats; Rats, Inbred Lew; Statistics, Nonparametric

2008
Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry.
    Journal of proteome research, 2011, Apr-01, Volume: 10, Issue:4

    Topics: Animals; Brain; Disease Models, Animal; Electron Transport Complex II; Galantamine; Gas Chromatography-Mass Spectrometry; Huntington Disease; Metabolome; Metabolomics; Mitochondria; Nitro Compounds; Nootropic Agents; Oxidative Stress; Propionates; Rats; Rats, Sprague-Dawley

2011
Treatment of Huntington's disease with galantamine.
    International clinical psychopharmacology, 2004, Volume: 19, Issue:1

    Topics: Adult; Cholinesterase Inhibitors; Galantamine; Humans; Huntington Disease; Male; Motor Skills

2004